logo
What to know about Trump's potential change in federal marijuana policy

What to know about Trump's potential change in federal marijuana policy

Boston Globe19 hours ago
What's the federal policy on marijuana?
Possessing marijuana remains a federal crime punishable by fines and prison time. Selling or cultivating marijuana is a more serious offense, punishable by prison sentences of five years to life, depending on the quantity of the drug.
Advertisement
The Justice Department last year proposed to reclassify marijuana from a Schedule I drug, alongside heroin and LSD, to a less dangerous Schedule III substance, which includes such things as ketamine and some anabolic steroids. But that switch involved a lengthy bureaucratic process.
Get Starting Point
A guide through the most important stories of the morning, delivered Monday through Friday.
Enter Email
Sign Up
Nearly 43,000 public comments were submitted to the federal government about the proposed change. The Drug Enforcement Administration was still in the review process when Trump succeeded Biden in January, triggering a re-examination of policies across the federal government.
What would reclassifying marijuana mean?
Reclassifying marijuana would not make it legal for recreational use by adults nationwide. Rather, it would change the way it's regulated and taxed.
Federal income tax deductions for business expenses aren't available to enterprises involved in 'trafficking' any Schedule I or II drug. Changing marijuana to a Schedule III drug could mean significant tax savings for businesses licensed to sell marijuana in states where it is legal.
Advertisement
It also could make it easier to research marijuana, since it's very difficult to conduct authorized clinical studies on Schedule I substances.
Due to the potential for federal penalties, many banks and financial institutions don't provide debit or credit services, loans or other common banking products to marijuana businesses authorized under state laws. That's unlikely to change merely by rescheduling marijuana under the federal Controlled Substances Act, according to a Congressional Research Service report.
What is there for Trump to consider?
Trump is weighing the pros and cons of a marijuana policy change, noting it's a 'very complicated subject.'
'I've heard great things having to do with medical' use of marijuana and 'bad things having to do with just about everything else,' Trump said Monday.
Marijuana advocacy groups have long pushed for the federal government to soften its stance. As a candidate, Trump appeared open to relaxed regulation, posting on his social media platform last year that he would 'focus on research to unlock the medical uses of marijuana to a Schedule 3 drug.'
But reclassification faces resistance from some conservatives and law enforcement groups. The National Sheriffs' Association was among those submitting written opposition, highlighting prior determinations that marijuana has a 'high abuse potential' and pointing to cases of 'extreme intoxication' and fatal vehicle crashes.
What's happening in the states?
The medical use of marijuana is already allowed in 40 states and the District of Columbia. Over the past dozen years, the number of jurisdictions legalizing recreational marijuana for adults rose rapidly to 24 states and the District of Columbia.
Advertisement
But the movement suffered some recent setbacks.
Ballot measures to legalize recreational marijuana failed last fall in Florida, North Dakota and South Dakota. Florida's measure received a majority vote, which would have been sufficient in most states, but fell short of the 60% threshold needed to approve amendments to the state constitution.
Idaho lawmakers this year referred a proposed constitutional amendment to the ballot that would forbid citizen initiatives to legalize marijuana and instead leave such decisions only to the Legislature.
Initiatives continue elsewhere to try to place recreational marijuana on the ballot, including in Oklahoma, where voters defeated a measure in 2023.
What does the data say about marijuana use?
About 6 in 10 voters across the country said they favor legalizing recreational use nationwide, according to AP VoteCast, a survey of more than 120,000 U.S. voters conducted during last year's election.
Polling from Gallup shows support for marijuana legalization has grown significantly, from just 36% support in 2005 to 68% last year.
Marijuana use has also increased. More than 64 million Americans age 12 and older — or 22.3% of people — used marijuana during the past year, according to a 2024 national survey released recently by the federal Substance Abuse and Mental Health Services Administration. That was up from 19% of people in 2021.
The growth in marijuana use was driven by adults aged 26 and older, according to the survey. However, people ages 18-25 remained the most likely to partake in marijuana, with 35% reporting use during the past year.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump Wants to Change Census to Exclude Illegal Immigrants—What to Know
Trump Wants to Change Census to Exclude Illegal Immigrants—What to Know

Epoch Times

timea minute ago

  • Epoch Times

Trump Wants to Change Census to Exclude Illegal Immigrants—What to Know

President Donald Trump is seeking to change how the U.S. Census Bureau collects data and exclude illegal immigrants from the U.S. Census. Trump ordered the Commerce Department to do so and announced the plan via a post to Truth Social, writing that the department would begin work on a 'new and highly accurate CENSUS based on modern day facts and figures and, importantly, using the results and information gained from the Presidential Election of 2024.'

Healthy Returns: FDA launches program to streamline creation of new U.S. drug manufacturing sites
Healthy Returns: FDA launches program to streamline creation of new U.S. drug manufacturing sites

CNBC

timea minute ago

  • CNBC

Healthy Returns: FDA launches program to streamline creation of new U.S. drug manufacturing sites

A new program from the Trump administration aims to make setting up manufacturing plants in the U.S. less of a headache for the pharmaceutical industry. The Food and Drug Administration on Thursday announced a new "PreCheck" program, which will use a two-phase approach to help boost domestic drug manufacturing after it shrunk dramatically over the past two decades. The announcement is a direct response to President Donald Trump's executive order in May calling on the FDA to reduce regulatory hurdles for domestic drug production in the U.S.. That order asked the agency to cut the amount of time it takes to approve new plants by eliminating unnecessary requirements, while also increasing the fees for and inspections of manufacturing facilities abroad. It follows a flurry of plans for new U.S. manufacturing investments from several drugmakers, such as Johnson & Johnson, AbbVie and Eli Lilly, in a bid to build goodwill with Trump. Still, the president could impose tariffs on pharmaceuticals imported into the U.S. any day now — a move that the industry argues could harm innovation and patient access to certain treatments. So, why has Trump made reshoring drug production a key facet of his trade policy? More than half of pharmaceuticals distributed in the U.S. are manufactured overseas, according to a release from the FDA. Only 11% of companies that produce active pharmaceutical ingredients are based in the U.S., while a significant share are in China and India, the agency added. The White House also estimates that it can currently take five to 10 years to build new manufacturing capacity for pharmaceuticals, which it previously called "unacceptable from a national-security standpoint." "Our gradual overreliance on foreign drug manufacturing has created national security risks," FDA Commissioner Dr. Marty Makary said in the release on Thursday. "The FDA PreCheck initiative is one of many steps FDA is taking that can help reverse America's reliance on foreign drug manufacturing and ensure that Americans have a resilient, strong, and domestic drug supply." Here's how the two phases of the program work: The FDA will host a public meeting on Sept. 30, where it will present on the program and discuss other proposals to "overcome current onshoring challenge," among other issues. Until then, concrete details on the program are sparse. It's unclear what requirements the FDA could eliminate, and how much less time it could take to approve new sites. We'll continue to watch as this program gets finalized and implemented, so stay tuned for our coverage! Feel free to send any tips, suggestions, story ideas and data to Annika at Like it or not, more and more patients are turning to OpenAI's artificial intelligence chatbot ChatGPT to answer questions about their health care. And the company is paying attention. OpenAI launched its latest large-scale AI model called GPT-5 last week, and the startup said it's the "best model yet" for health-related queries. The product is designed to proactively flag health concerns, ask relevant questions and generate more precise and reliable responses, the company said in a blog post. "Health care is maybe the area where there's the strongest improvement of any (is this one extra?) of any category," OpenAI CEO Sam Altman told CNBC's "Squawk Box" in an interview about GPT-5 on Friday. Altman said health-related questions make up a "huge fraction" of ChatGPT usage. In a post on X, he said he hopes GPT-5's health capabilities will "provide real service to people." OpenAI said GPT-5 scores "significantly higher" than previous models on its health-care AI benchmark called Health Bench. The company released Health Bench in May, and it's designed to measure how well AI models perform in realistic health scenarios. HealthBench was developed alongside 262 doctors from 60 countries. OpenAI said it's based on 5,000 conversations that simulate interactions between individual users or clinicians and AI models. OpenAI is also touting GPT-5 as a helpful tool for medical research. The company released a two-minute-long video with Dr. Derya Unutmaz, a professor and human immunologist, which demonstrates how he has been using the model. Unutmaz said GPT-5 is able to help him brainstorm, interpret data and save him time by predicting outcomes of potential experiments. "I think GPT-5 will help the patients to advocate for themselves, and I think that will empower the patients to feel more confident when they talk to their doctors," Unutmaz said in the video. Feel free to send any tips, suggestions, story ideas and data to Ashley at

Newsom mocks Trump in all-caps post promising a 2026 Democratic victory
Newsom mocks Trump in all-caps post promising a 2026 Democratic victory

USA Today

time2 minutes ago

  • USA Today

Newsom mocks Trump in all-caps post promising a 2026 Democratic victory

California Gov. Gavin Newsom mocked President Donald Trump with an all-caps tweet amid a heated redistricting effort in Texas. WASHINGTON − California Democratic Gov. Gavin Newsom mocked President Donald Trump with an all-caps tweet amid a heated redistricting effort in Texas that could give Republicans up to five more seats in the U.S. House of Representatives next year. Mimicking Trump's all-caps social media style, Newsom trolled the president as "DONALD 'TACO' TRUMP," and suggested California would soon go forward with its own redistricting effor to offset the Republican effort in Texas. The post comes as Newsom urged Trump in an Aug. 11 letter to stop the redistricting efforts, arguing that Trump was 'playing with fire' and 'risking the destabilization of our democracy.' Newsom added that if Trump doesn't stand down, he would redraw the congressional map in California to counter the Texas effort. 'DONALD 'TACO' TRUMP, AS MANY CALL HIM, 'MISSED' THE DEADLINE!!! CALIFORNIA WILL NOW DRAW NEW, MORE 'BEAUTIFUL MAPS,' THEY WILL BE HISTORIC AS THEY WILL END THE TRUMP PRESIDENCY (DEMS TAKE BACK THE HOUSE!). BIG PRESS CONFERENCE THIS WEEK WITH POWERFUL DEMS AND GAVIN NEWSOM — YOUR FAVORITE GOVERNOR — THAT WILL BE DEVASTATING FOR 'MAGA.' THANK YOU FOR YOUR ATTENTION TO THIS MATTER! — GN,' Newsom wrote on X, imitating Trump's language in his Truth Social posts. "TACO," an acronym for "Trump Always Chickens Out," is a reference to Trump's ever-shifting tariff deadlines. Newsom's post received more than 3.2 million views. Democratic governors Kathy Hochul of New York and J.B. Pritzker of Illinois have also previously threatened to launch their own redistricting efforts that could give Democrats a boost, sparking a tit-for-tat. Redistricting is required by federal law every 10 years following the release of new U.S. Census Bureau figures. However, Trump encouraged Texas Republicans to jumpstart the process in the middle of the decade. The Texas Senate on Aug. 12 approved the new set of congressional lines by a vote of 19-2, according to the Texas Tribune. The Texas redistricting effort is stalled in the state House, where most Democratic representatives have fled the state, denying majority Republicans a quorum needed to pass the measure. Trump said Aug. 5 that Republicans "are entitled to five more seats" in Texas because of his 2024 election victory there. Republicans currently hold the U.S. House by a razor thin margin. Newsom said that he is eyeing a special election in November so voters could weigh in on a ballot measure that would allow for a new House map in California ahead of the 2026 midterms.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store